These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30925286)

  • 1. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination.
    Zhu D; Hu C; Fan F; Qin Y; Huang C; Zhang Z; Lu L; Wang H; Sun H; Leng X; Wang C; Kong D; Zhang L
    Biomaterials; 2019 Jun; 206():25-40. PubMed ID: 30925286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses.
    Wang N; Zuo Y; Wu S; Huang C; Zhang L; Zhu D
    Acta Pharm Sin B; 2022 Dec; 12(12):4486-4500. PubMed ID: 36561992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pickering emulsion-guided monomeric delivery of monophosphoryl lipid A for enhanced vaccination.
    Du Y; Lv J; Hao Z; Li Z; Song T; Ge H; Wang H; Yu Z; Xie Z; Li D; Liu Y
    J Control Release; 2024 Oct; 374():39-49. PubMed ID: 39111597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
    Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
    Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination.
    Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z
    ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
    Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
    ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
    Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
    J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose derivative and lipid A dually decorated cationic liposomes as an effective cold chain free oral mucosal vaccine adjuvant-delivery system.
    Wang N; Wang T; Zhang M; Chen R; Niu R; Deng Y
    Eur J Pharm Biopharm; 2014 Sep; 88(1):194-206. PubMed ID: 24769065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanoma.
    Zou C; Jiang G; Gao X; Zhang W; Deng H; Zhang C; Ding J; Wei R; Wang X; Xi L; Tan S
    Nanomedicine; 2019 Nov; 22():102092. PubMed ID: 31593795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.
    Silva JM; Zupancic E; Vandermeulen G; Oliveira VG; Salgado A; Videira M; Gaspar M; Graca L; Préat V; Florindo HF
    J Control Release; 2015 Jan; 198():91-103. PubMed ID: 25483429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.
    Ahmed KK; Geary SM; Salem AK
    J Pharm Sci; 2016 Mar; 105(3):1173-9. PubMed ID: 26886334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
    Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
    J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.